Jessy J Duran Ramirez, Roger D Kouyos, Irene Abela, Charles Beguelin, Marco Bongiovanni, Philip Bruggmann, Alexandra Calmy, Matthias Cavassini, Alexia Cusini, Mirjam de Roche, Luigia Elzi, Andrée Friedl, Rosamaria Fulchini, Chistoph Fux, David Haerry, Benjamin Hampel, Markus Herold, Philipp Kaiser, Helen Kovari, Patrick Schmid, Delphine Sculier, Marcel Stöckle, Philip E Tarr, Frédéric Tissot, Jonathan Tschopp, Gilles Wandeler, Andri Rauch, Huldrych F Günthard, Katharina Kusejko
{"title":"Improving cohort coverage estimation using a data triangulation framework: the Swiss HIV Cohort Study example.","authors":"Jessy J Duran Ramirez, Roger D Kouyos, Irene Abela, Charles Beguelin, Marco Bongiovanni, Philip Bruggmann, Alexandra Calmy, Matthias Cavassini, Alexia Cusini, Mirjam de Roche, Luigia Elzi, Andrée Friedl, Rosamaria Fulchini, Chistoph Fux, David Haerry, Benjamin Hampel, Markus Herold, Philipp Kaiser, Helen Kovari, Patrick Schmid, Delphine Sculier, Marcel Stöckle, Philip E Tarr, Frédéric Tissot, Jonathan Tschopp, Gilles Wandeler, Andri Rauch, Huldrych F Günthard, Katharina Kusejko","doi":"10.1097/QAD.0000000000004523","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To improve estimation of cohort coverage in the Swiss HIV Cohort Study (SHCS) using a data triangulation framework that compares SHCS data with multiple external data sources.</p><p><strong>Design: </strong>Retrospective longitudinal analysis of the SHCS.</p><p><strong>Methods: </strong>Cohort coverage of HIV diagnoses, AIDS diagnoses, and antiretroviral therapy (ART) uptake was triangulated across SHCS data (1985-2023), national HIV/AIDS surveillance (1985-2023), longitudinal antiretroviral therapy (ART) sales data (2017-2024), and a targeted literature comparison. Temporal trends in cohort coverage were assessed, and demographic representativeness was evaluated by sex, age, HIV acquisition mode, and region. Mean cohort coverage estimates were calculated for three outcomes: HIV and AIDS diagnoses (Step 1) and ART uptake (Step 2).</p><p><strong>Results: </strong>Over 38 years, mean SHCS coverage was 62.4% for HIV diagnoses, 74.0% for AIDS, and 64.9% for ART uptake, consistent with literature-based estimates. Coverage of HIV diagnoses declined in recent years, and geographical heterogeneity was observed. The SHCS remained broadly representative across most subgroups; however, females, older adults, and people with heterosexually acquired HIV or using psychoactive substances were underrepresented, while people on single-tablet and salvage ART regimens were overrepresented.</p><p><strong>Conclusions: </strong>A data triangulation framework provides a practical approach for monitoring cohort coverage and representativeness. While the SHCS captures a broadly representative sample of diagnosed individuals, tailored strategies are needed to improve inclusion of underrepresented subgroups and maintain cohort coverage. Sustained monitoring is essential to ensure that cohort-based research remains generalizable and continues to inform clinical care and public health responses in Switzerland and beyond.</p>","PeriodicalId":7502,"journal":{"name":"AIDS","volume":" ","pages":"1314-1326"},"PeriodicalIF":2.9000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13566368/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QAD.0000000000004523","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/10 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: To improve estimation of cohort coverage in the Swiss HIV Cohort Study (SHCS) using a data triangulation framework that compares SHCS data with multiple external data sources.
Design: Retrospective longitudinal analysis of the SHCS.
Methods: Cohort coverage of HIV diagnoses, AIDS diagnoses, and antiretroviral therapy (ART) uptake was triangulated across SHCS data (1985-2023), national HIV/AIDS surveillance (1985-2023), longitudinal antiretroviral therapy (ART) sales data (2017-2024), and a targeted literature comparison. Temporal trends in cohort coverage were assessed, and demographic representativeness was evaluated by sex, age, HIV acquisition mode, and region. Mean cohort coverage estimates were calculated for three outcomes: HIV and AIDS diagnoses (Step 1) and ART uptake (Step 2).
Results: Over 38 years, mean SHCS coverage was 62.4% for HIV diagnoses, 74.0% for AIDS, and 64.9% for ART uptake, consistent with literature-based estimates. Coverage of HIV diagnoses declined in recent years, and geographical heterogeneity was observed. The SHCS remained broadly representative across most subgroups; however, females, older adults, and people with heterosexually acquired HIV or using psychoactive substances were underrepresented, while people on single-tablet and salvage ART regimens were overrepresented.
Conclusions: A data triangulation framework provides a practical approach for monitoring cohort coverage and representativeness. While the SHCS captures a broadly representative sample of diagnosed individuals, tailored strategies are needed to improve inclusion of underrepresented subgroups and maintain cohort coverage. Sustained monitoring is essential to ensure that cohort-based research remains generalizable and continues to inform clinical care and public health responses in Switzerland and beyond.
期刊介绍:
Publishing the very latest ground breaking research on HIV and AIDS. Read by all the top clinicians and researchers, AIDS has the highest impact of all AIDS-related journals. With 18 issues per year, AIDS guarantees the authoritative presentation of significant advances. The Editors, themselves noted international experts who know the demands of your work, are committed to making AIDS the most distinguished and innovative journal in the field. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.